Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

279 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Real-World Outcomes of Trastuzumab Deruxtecan in Patients With HER2+ Metastatic Breast Cancer: The DE-REAL Study.
Botticelli A, Caputo R, Scagnoli S, Pisegna S, De Laurentiis M, Curigliano G, Lambertini M, Pantano F, Palazzo A, Paris I, Vernieri C, Tedesco B, Giampaglia M, Palleschi M, Ballatore Z, Alesini D, D'Auria G, Fabbri A, Rossi L, Verrazzo A, Scafetta R, Marinelli D, Sposetti C, Barberi V, Strigari L, Marchetti P, Santini D, Fabi A. Botticelli A, et al. Among authors: strigari l. Oncologist. 2024 Apr 4;29(4):303-310. doi: 10.1093/oncolo/oyad308. Oncologist. 2024. PMID: 37995313 Free PMC article.
CD137+ and regulatory T cells as independent prognostic factors of survival in advanced non-oncogene addicted NSCLC patients treated with immunotherapy as first-line.
Gelibter A, Asquino A, Strigari L, Zizzari IG, Tuosto L, Scirocchi F, Pace A, Siringo M, Tramontano E, Bianchini S, Bellati F, Botticelli A, Paoli D, Santini D, Nuti M, Rughetti A, Napoletano C. Gelibter A, et al. Among authors: strigari l. J Transl Med. 2024 Apr 3;22(1):329. doi: 10.1186/s12967-024-05142-6. J Transl Med. 2024. PMID: 38570798 Free PMC article.
Unraveling the safety of adjuvant radiotherapy in prostate cancer: impact of older age and hypofractionated regimens on acute and late toxicity - a multicenter comprehensive analysis.
Buwenge M, Macchia G, Cavallini L, Cortesi A, Malizia C, Bianchi L, Ntreta M, Arcelli A, Capocaccia I, Natoli E, Cilla S, Cellini F, Tagliaferri L, Strigari L, Cammelli S, Schiavina R, Brunocilla E, Morganti AG, Deodato F. Buwenge M, et al. Among authors: strigari l. Front Oncol. 2023 Dec 13;13:1281432. doi: 10.3389/fonc.2023.1281432. eCollection 2023. Front Oncol. 2023. PMID: 38192625 Free PMC article.
How smart is artificial intelligence in organs delineation? Testing a CE and FDA-approved Deep-Learning tool using multiple expert contours delineated on planning CT images.
Strolin S, Santoro M, Paolani G, Ammendolia I, Arcelli A, Benini A, Bisello S, Cardano R, Cavallini L, Deraco E, Donati CM, Galietta E, Galuppi A, Guido A, Ferioli M, Laghi V, Medici F, Ntreta M, Razganiayeva N, Siepe G, Tolento G, Vallerossa D, Zamagni A, Morganti AG, Strigari L. Strolin S, et al. Among authors: strigari l. Front Oncol. 2023 Mar 2;13:1089807. doi: 10.3389/fonc.2023.1089807. eCollection 2023. Front Oncol. 2023. PMID: 36937399 Free PMC article.
Targeting of H19/cell adhesion molecules circuitry by GSK-J4 epidrug inhibits metastatic progression in prostate cancer.
Pecci V, Troisi F, Aiello A, De Martino S, Carlino A, Fiorentino V, Ripoli C, Rotili D, Pierconti F, Martini M, Porru M, Pinto F, Mai A, Bassi PF, Grassi C, Gaetano C, Pontecorvi A, Strigari L, Farsetti A, Nanni S. Pecci V, et al. Among authors: strigari l. Cancer Cell Int. 2024 Feb 5;24(1):56. doi: 10.1186/s12935-024-03231-6. Cancer Cell Int. 2024. PMID: 38317193 Free PMC article.
Augmented reality in brachytherapy: A narrative review.
Ferioli M, Medici F, Forlani L, Cilla S, Fionda B, Cammelli S, Strigari L, Tagliaferri L, Morganti AG, Buwenge M. Ferioli M, et al. Among authors: strigari l. J Contemp Brachytherapy. 2024 Feb;16(1):57-66. doi: 10.5114/jcb.2024.137779. Epub 2024 Feb 29. J Contemp Brachytherapy. 2024. PMID: 38584890 Free PMC article. Review.
279 results